Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hollowing in patients over the age of 21.

In a beauty editor dream world, hyaluronic acid would spray out from fountains and sidewalk misters to keep our skin plump and dewy—highlighter would be put out of business. But until that day, we’ll ...